Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

Abstract Objective Phase III clinical trials of the tumour necrosis factor inhibitors SB4, SB2, and SB5 (biosimilars to etanercept, infliximab, and adalimumab, respectively) have demonstrated efficacy in moderate-to-severe rheumatoid arthritis (RA). Data from these trials were used to identify basel...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek, Jeehoon Ghil
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-08-01
coleção:	Arthritis Research & Therapy
Assuntos:	Biosimilar TNF inhibitors Rheumatoid arthritis Radiography
Acesso em linha:	http://link.springer.com/article/10.1186/s13075-020-02267-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!